Interestingly, genomic analysis of 115 BRCA1/2 breast tumors revealed an inverse association between homologous recombination deficiency (HRD) and immunogenicity despite a higher mutational burden and neoantigen load (41). Here, BRCA1 is linked to breast neoplasm.